All studies
RecruitingOBSERVATIONAL

DCP (RaDiCo Cohort) (RaDiCo-DCP)

This study, called RaDiCo-DCP, is all about Primary Ciliary Dyskinesia (PCD), a rare lung condition that makes it hard to clear mucus. Researchers want to better understand PCD and improve how people with the condition are cared for. They are collecting information from patients to learn more about the illness, including why some people get sicker than others, and how it affects quality of life, including ear, nose, and throat problems, and fertility. The study also aims to discover new genes linked to PCD and see how genetic differences might lead to different symptoms. By gathering this detailed information, doctors hope to find ways to give earlier and more personalised care to those with PCD.

At a glance

Status
Recruiting
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrolment target
300
Start
01 May 2017
Estimated completion
01 May 2027

What is this study about?

Imagine tiny, hair-like structures called cilia lining your airways, working to sweep away germs and mucus. In people with Primary Ciliary Dyskinesia (PCD), these cilia don't work properly. This means germs and mucus can build up, leading to frequent infections in the nose, sinuses, and lungs, often starting in childhood. Over time, this can cause problems like nasal polyps (growths in the nose) and bronchodilations (damaged and widened airways).

This study is important because about half of people with PCD also have their internal organs, like the heart and liver, on the opposite side of their body (a condition called situs inversus). Men with PCD can also experience infertility, and women might have a higher risk of miscarriages or ectopic pregnancies. Sadly, about a third of patients might eventually develop severe breathing problems. Currently, we don't fully understand why some people with PCD have more severe symptoms than others, or why the quality of life is affected in certain ways. This study aims to fill these gaps in our knowledge.

The RaDiCo-DCP study will collect information from people with PCD. The main goal is to find out what factors might predict how severe the condition becomes, which could lead to earlier and more personalised care. Researchers also want to understand how PCD affects daily life, especially problems with the ears, nose, and throat, and fertility in adults. They will also look closely at the cilia themselves to understand how they are abnormal, and search for new genes that cause PCD. All of this information will help doctors better understand the disease and improve care for patients.

Key takeaways

  • This study aims to improve understanding and care for Primary Ciliary Dyskinesia (PCD).
  • It collects information from patients' existing medical records and routine visits.
  • No new treatments or medications are involved.
  • The goal is to find factors predicting disease severity and assess quality of life.
  • Researchers are also looking for new genes linked to PCD.
  • Participation helps future patients with more personalised and effective care.

Who may be eligible?

This study is looking for people who have a confirmed diagnosis of Primary Ciliary Dyskinesia (PCD). You would be eligible if your PCD diagnosis has been confirmed by having a condition called Kartagener's syndrome, or if specific problems with your cilia have been identified, or if you have a clear change in a gene known to cause PCD. You would also need to have at least one annual check-up appointment for your condition.

However, you would not be able to join the study if your diagnosis of PCD is not fully confirmed. Also, if you have another ongoing health condition that is changing or developing and might make it difficult to assess your PCD-related symptoms, then this study might not be suitable for you at this time.

All adults and children, regardless of their gender, are welcome to be considered for this study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Have I been definitively diagnosed with Primary Ciliary Dyskinesia (PCD)?
  2. Does my diagnosis include Kartagener's syndrome, specific ciliary problems, or a clear gene fault for PCD?
  3. Do I attend at least one annual follow-up visit for my PCD?
  4. Do I have any other major health conditions that are rapidly changing and might affect how my PCD is assessed?
Answer every question to see your result.

What does participation involve?

This study is gathering information from patients over time rather than testing new treatments or medications. If you join, you wouldn't be given any new drugs or asked to change your current treatment. Instead, the researchers would collect information from your regular medical check-ups and existing health records. This information might include details about your symptoms, how your PCD has progressed, how it affects your daily life (your quality of life), and any related health issues like ENT problems or fertility. You would not need to attend extra visits specifically for the study beyond your usual annual check-ups. The study involves collecting data from these routine visits over an unspecified period.

Potential risks and benefits

This study is primarily collecting information from your existing medical records and routine check-ups. This means there are no physical risks involved like with new medications or procedures. The main benefit is that your information will help doctors understand Primary Ciliary Dyskinesia much better, leading to improved care for patients in the future. The findings could help identify early signs of problems, allow for more personalised treatments, and improve quality of life for people with PCD. You can decide to withdraw your participation at any time, and this will not affect your medical care.

Locations (32)

  • Hôpital Jean Minjoz
    Verified postcode
    Besançon, France· Not yet recruiting
  • Hôpital Pellegrin-Enfants
    Verified postcode
    Bordeaux, France· Not yet recruiting
  • CHU de Caen
    Verified postcode
    Caen, France· Not yet recruiting
  • Hôpital Clémenceau
    Verified postcode
    Caen, France· Not yet recruiting
  • Centre Hospitalier Intercommunal de Créteil
    Verified postcode
    Créteil, France· Recruiting
  • Centre Hospitalier Intercommunal de Créteil
    Verified postcode
    Créteil, France· Not yet recruiting
  • Centre Hospitalier Intercommunal de Créteil
    Verified postcode
    Créteil, France· Recruiting
  • Hôpital Henri Mondor
    Verified postcode
    Créteil, France· Recruiting
  • Hôpital Le Bocage
    Verified postcode
    Dijon, France· Not yet recruiting
  • Hôpital Bicêtre
    Verified postcode
    Le Kremlin-Bicêtre, France· Recruiting
  • Hôpital Jeanne de Flandre
    Verified postcode
    Lille, France· Recruiting
  • Hôpital Femme-Mère-Enfant
    Verified postcode
    Lyon, France· Recruiting

Common questions

What is Primary Ciliary Dyskinesia (PCD)?

PCD is a rare genetic condition where tiny hair-like structures in your airways, called cilia, don't work properly, leading to breathing problems.

Will I have to take new medication if I join?

No, this study only collects information from your existing medical records and routine check-ups; you won't be given any new medication.

How will my information be used?

Your information will help researchers better understand PCD, find new genes, identify factors that predict severity, and ultimately improve patient care.

Do I need extra hospital visits?

No, the study will gather information from your usual annual check-up appointments; you won't need to attend extra visits.

Can children join this study?

Yes, people of all ages, including children, are welcome to be considered for this study if they meet the other criteria.

How to find out more

Bernard MAITRE

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "DCP (RaDiCo Cohort) (RaDiCo-DCP)…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.